"A US company is set to begin a trial of a vaccine which it claims halts the progress of multiple sclerosis. PharmaFrontiers is to test its tailor-made vaccine on 100 patients with MS, after a small-scale study showed promise. The degenerative disease attacks the nervous system and affects 2.5m people worldwide, of which 1% die each year."
read more | digg story
